Literature DB >> 33576776

Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections.

Susan Tuddenham1, Jacques Ravel2,3, Jeanne M Marrazzo4.   

Abstract

Unique compositional and functional features of the cervicovaginal microbiota have been associated with protection against and risk for sexually transmitted infections (STI). In men, our knowledge of the interaction between the penile microbiota and STI is less developed. The current state of our understanding of these microbiota and their role in select STIs is briefly reviewed, along with strategies that leverage existing findings to manipulate genital microbiota and optimize protection against STIs. Finally, we focus on major research gaps and present a framework for future studies.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Lactobacillus; STI; anaerobes; microbiome; penile; vagina

Mesh:

Year:  2021        PMID: 33576776      PMCID: PMC8206802          DOI: 10.1093/infdis/jiaa762

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  148 in total

1.  Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.

Authors:  Jennifer E Balkus; Lisa E Manhart; Jeannette Lee; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

2.  Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source.

Authors:  E R Boskey; R A Cone; K J Whaley; T R Moench
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

3.  Vaginal microbiome transplantation in women with intractable bacterial vaginosis.

Authors:  Ahinoam Lev-Sagie; Debra Goldman-Wohl; Yotam Cohen; Mally Dori-Bachash; Avner Leshem; Uria Mor; Jacob Strahilevitz; Allon E Moses; Hagit Shapiro; Simcha Yagel; Eran Elinav
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

4.  Association between obesity and bacterial vaginosis as assessed by Nugent score.

Authors:  Rita T Brookheart; Warren G Lewis; Jeffrey F Peipert; Amanda L Lewis; Jenifer E Allsworth
Journal:  Am J Obstet Gynecol       Date:  2019-01-29       Impact factor: 8.661

5.  Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases.

Authors:  Jane R Schwebke; Jeannette Y Lee; Shelly Lensing; Susan S Philip; Harold C Wiesenfeld; Arlene C Seña; Nikole Trainor; Nincoshka Acevado; Lisa Saylor; Ann M Rompalo; Robert L Cook
Journal:  Clin Infect Dis       Date:  2015-11-26       Impact factor: 9.079

6.  Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.

Authors:  Rebecca M Brotman; Michelle D Shardell; Pawel Gajer; J Kathleen Tracy; Jonathan M Zenilman; Jacques Ravel; Patti E Gravitt
Journal:  J Infect Dis       Date:  2014-06-18       Impact factor: 5.226

7.  Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women.

Authors:  Katherine Fethers; Jimmy Twin; Christopher K Fairley; Freya J I Fowkes; Suzanne M Garland; Glenda Fehler; Anna M Morton; Jane S Hocking; Sepehr N Tabrizi; Catriona S Bradshaw
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 8.  Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis.

Authors:  Muriel Aldunate; Daniela Srbinovski; Anna C Hearps; Catherine F Latham; Paul A Ramsland; Raffi Gugasyan; Richard A Cone; Gilda Tachedjian
Journal:  Front Physiol       Date:  2015-06-02       Impact factor: 4.566

9.  Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.

Authors:  Paola Nardini; Rogers Alberto Ñahui Palomino; Carola Parolin; Luca Laghi; Claudio Foschi; Roberto Cevenini; Beatrice Vitali; Antonella Marangoni
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

10.  Longitudinal association of gonorrhea and bacterial vaginosis with repeat chlamydia diagnoses among U.S. Army women: a retrospective cohort analysis.

Authors:  Christian T Bautista; Eyako K Wurapa; Warren B Sateren; Bruce P Hollingsworth; Jose L Sanchez
Journal:  Mil Med Res       Date:  2018-10-30
View more
  4 in total

1.  Bacterial Vaginosis and Alcohol Consumption: A Cross-Sectional Retrospective Study in Baltimore, Maryland.

Authors:  Leah Froehle; Khalil G Ghanem; Kathleen Page; Heidi E Hutton; Geetanjali Chander; Matthew M Hamill; Elizabeth Gilliams; Susan Tuddenham
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

2.  The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance.

Authors:  Ryan T Ranallo; L Clifford McDonald; Alison Laufer Halpin; Thomas Hiltke; Vincent B Young
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

3.  Cervicovaginal Microbiota Predicts Neisseria gonorrhoeae Clinical Presentation.

Authors:  Angela Lovett; Arlene C Seña; Andrew N Macintyre; Gregory D Sempowski; Joseph A Duncan; Andreea Waltmann
Journal:  Front Microbiol       Date:  2022-02-10       Impact factor: 6.064

4.  Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.

Authors:  David Jose Delgado-Diaz; Brianna Jesaveluk; Joshua A Hayward; David Tyssen; Arghavan Alisoltani; Matthys Potgieter; Liam Bell; Elizabeth Ross; Arash Iranzadeh; Imane Allali; Smritee Dabee; Shaun Barnabas; Hoyam Gamieldien; Jonathan M Blackburn; Nicola Mulder; Steven B Smith; Vonetta L Edwards; Adam D Burgener; Linda-Gail Bekker; Jacques Ravel; Jo-Ann S Passmore; Lindi Masson; Anna C Hearps; Gilda Tachedjian
Journal:  Microbiome       Date:  2022-08-31       Impact factor: 16.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.